Dovato (Dolutegravir / Lamuvidine)

Save 60% on brand Dovato from Europe and over 85% on generic Dovato.

Click here for information on Emcure generics (Immediate availability)

For brand Dovato, Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.

According to the European Medicines Agency, brand name Dovato originating from Europe is manufactured at the following site(s): Glaxo Wellcome, S.A. Avda. Extremadura, 3 09400 Aranda De Duero Burgos Spain

Prescription Dovato is a combination drug containing both dolutegravir and lamuvidine for the treatment of HIV-1 where the disease is not resistant to either ingredient. Dovato is approved by the USFDA as a complete treatment for HIV-1 patients as a first treatment under these conditions. Dovato is not a cure for HIV however it keeps the amount of virus in the body at low levels, allowing your body's immune system to function and fight off other conditions and infections asscociated with AIDS.

Dovato is prescribed to adults and children over 12 years old (over 40kg weight). The dose of Dovato is usually 1 tablet daily with or without food however may be prescribed differently depending on the patient. Dovato does not work for everyone so your doctor will monitor the effectiveness of the medicine. Do not skip doses of Dovato even if you feel better. If you miss a dose of Dovato, take as soon as you remember unless it is almost time for your next dose.

When taking Dovato, avoid taking antacids at the same time as antacids will reduce the absorption of Dovato. Take the antacid 6 hours before treatment or 2 hours after treatment of Dovato only. If you take vitamins and supplements, also do not take at the same time as Dovato, unless it is part of your meal.

In 2019, when comparing Dovato cost to USA Dovato coupon price, InsulinHub was found to offer a discount of approximately 35% in Dovato savings. 

Buy Dovato from InsulinHub.com for the best Dovato cost.

Information about Dovato (Dolutegravir / Lamivudine)

Dovato is a fixed-dose combination medication that contains dolutegravir (an integrase strand transfer inhibitor) and lamivudine (a nucleoside reverse transcriptase inhibitor). It is used for the treatment of HIV-1 infection in adults and children weighing at least 30 kg.

Product Highlights

• Treatment of HIV-1 infection in adults and children (weighing at least 30 kg) as part of a combination antiretroviral regimen.

Key Ingredient

• Dolutegravir
• Lamivudine

Key Benefits

• Aids in lowering the viral load to undetectable levels.
• A single-tablet regimen simplifies adherence to treatment.
• Generally well-tolerated with fewer side effects compared to some other HIV treatments.

Direction of Use

• Dovato should be taken as prescribed by a healthcare provider. 
• The usual dosage is one tablet daily, which can be taken with or without food.
• It is essential to take it consistently to maintain effective viral suppression.

Safety Concerns

• Common side effects may include nausea, diarrhea, headache, fatigue, and insomnia. Serious side effects can include liver problems, allergic reactions, and changes in mood or behavior.
• Dovato can interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Avoid Dovato (Dolutegravir / Lamivudine) If

• You have a known hypersensitivity to dolutegravir, lamivudine, or any of the ingredients in Dovato.
• You are taking certain medications that can interact adversely with Dovato.
• You have severe liver disease or are experiencing other serious medical conditions that may contraindicate its use.